A joint event by URPP H2R (University of Zurich) and the Center for Life Sciences Law (Juristische Fakultät der Universität Basel)
The workshop «The Technology and Ethics of CRISPR» will focus on the potential uses and misuse of the genetic engineering tool CRISPR. The workshop will consolidate and spark interdisciplinary work regarding three main perspectives: (i) Perspectives on CRISPR Gene Editing, (ii) Current Developments / Spotlights on Germline Gene Editing, (iii) Spotlights on Somatic Gene Editing.
The medical research on CRISPR has to be embedded within a broad societal debate including ethical, legal and economic considerations. Within a joint statement the United Kingdom’s “Nuffield Council on Bioethics”, the French “Comité Consultatif National d’Éthique pour les sciences de la vie et de la santé” (CCNE) and the German ethics council “Deutscher Ethikrat” called on governments and stakeholders around the world to take action and to put ethical considerations at the core of such discussions as well as within global dialogues.
International speakers, experts from the University Research Priority Program (URPP) "Human Reproduction Reloaded | H2R" of the University of Zurich and the Center for Life Sciences Law of the University of Basel as well as early-career researchers will discuss these topics in an interdisciplinary setting.
The workshop is supported by Congressi Stefano Franscini (CSF) / ETH Zurich.
We are inviting junior and senior researchers from various disciplines to submit a research abstract and participate in our workshop. The selection will be based on previous research achievements in the field. The PhDs and postdocs will present a research poster on site to foster interdisciplinary exchange.
Please send a research abstract (max. 500 words) to firstname.lastname@example.org
Prof. Tommaso Cavazza (University of Zurich)
Prof. Michael Coors (University of Zurich)
Prof. Dieter Egli (Columbia University, New York)
Prof. Bijan Fateh-Moghadam (University of Basel)
Dr. Norah Fogarty (King’s College London)
Prof. Alfred Früh (University of Basel)
Dr. Philippe Girard (Vice Director Swissmedic)
Dr. Javier Guzman (Center for Global Development, Washington, D.C.)
Dr. Stefan Kohler (Attorney-at-Law, Vischer)
Prof. Michael Krauthammer (University of Zurich)
Prof. Duncan Matthews (Queen Mary University London)
Prof. Gerald Schwank (University of Zurich)
Prof. Claudia Wiesemann (University of Göttingen)
Dr. Martin Wilming (Patent Attorney, HEPP)